©The Author(s) 2025.
World J Clin Cases. Nov 26, 2025; 13(33): 110641
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.110641
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.110641
Table 3 Primary outcomes after propensity matching, n (%)
| Outcomes | RA+DM (n = 50423) | RA-DM (n = 50423) | P value |
| Interstitial lung diseases | 1360 (2.25) | 672 (1.11) | < 0.001 |
| Usual interstitial pneumonia/pulmonary fibrosis | 840 (1.67) | 227 (0.45) | < 0.001 |
| Non-specific interstitial pneumonia | 494 (0.98) | 133 (0.26) | < 0.001 |
| Eosinophilic lung disease | 18 (0.04) | 78 (0.15) | < 0.001 |
| Respiratory bronchiolitis interstitial lung disease | 8 (0.02) | 5 (0.01) | < 0.001 |
| Cryptogenic organizing pneumonia | 17 (0.03) | 1 (< 0.01) | 0.057 |
| Acute interstitial pneumonitis | 11 (0.02) | 5 (0.01) | < 0.001 |
- Citation: Sutton J, Khattar G, Saliba F, Mourad O, Aoun L, Jdaidani J, Qandil H, Kaspar C, Abu-Baker S, Almardini S, Haddadin F, Bou Sanayeh E, Slobodnick A. Impact of type 2 diabetes mellitus on interstitial lung disease risk in rheumatoid arthritis. World J Clin Cases 2025; 13(33): 110641
- URL: https://www.wjgnet.com/2307-8960/full/v13/i33/110641.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i33.110641